The Challenge: “Medication Adherence in Nogata City,
From Osaka to the world! Collaborative Overseas Expansion Support Project: 'Healthcare Companies Pioneering the World' (Deadline: 5/1).
5/12 16 life sciences start-ups take to the stage! Nakanoshima Qross Innovation Challenge
New Challenge Application:
Call for Collaborators to Unlock the Potential of Children Who Refuse to Attend School
News
READ MORE- Partner2026.4.27HORIBA, Ltd., Richmond Pharmacology, and NIJI.RIBBON joined i2.JP
- Partner2026.4.20Eisai Co., Ltd, Light Touch Technology Inc., and yuruttokaigo Inc. joined i2.JP
- Collaborations2026.4.13The Challenge: “Medication Adherence in Nogata City, Fukuoka Prefecture”, Exploring the Root Causes and Seeking Solutions!
- Event2026.4.13From Osaka to the world! Collaborative Overseas Expansion Support Project: 'Healthcare Companies Pioneering the World' (Deadline: 5/1).
Collaborations
READ MORE-
The Challenge: “Medication Adherence in Nogata City, Fukuoka Prefecture”, Exploring the Root Causes and Seeking Solutions!
Astem×Bridge×i2.JP -
Roundtable Talk
"Thinking about the use of open innovation by local governments/organizations"Matsumoto Health Lab x QUINTBRIDGE x i2.JP -
A partnership between a Singaporean startup and a Japanese imaging CRO to tackle challenges surrounding inhaled drug therapies
Meracle x Micron -
The presenters, reverse pitch topics, and participants are all diverse! A collection of unique players create collective knowledge across disciplines
LINK-J ×i2.JP×QUINTBRIDGE -
JTB×AZ
After the company-wide project taxi company's own COPD awareness campaign is underway (Part2)JTB -
JTB×AZ
Educational activities at a taxi company to raise awareness of COPD among those at risk and encourage them to seek medical attention (Part1)JTB -
～Celebrating the 4th anniversary of “i2.JP”～
As a pioneer in co-creation for healthcare to achieve "patient-centered" social implementation with "diversity" and "collective intelligence”President and Representative Director of AstraZeneca K. K. -
Fujitsu×AZ
Co-create ideas as "One Team" for new projects that address patient issues.Fujitsu -
Ask our partners: Matching via i2.JP
Co-creation & innovation begin with "talking"! The unexpected turns reveal new themes and insightsMedical Principle Co., Ltd. -
Carepro x AZ
Ovarian Cancer Awareness Project (Part2)
Seminar collaborating with influencers to reach those less interested in ovarian cancerCarepro -
OiTr×AZ
Ovarian Cancer Awareness Project（Part1）
Restroom signage for the high-risk population, with surveys to explore behavior changeOiTr -
Looking for partners to take on challenges together!- Business matching event to celebrate the 3rd anniversary of i2.JP
CIC Tokyo × QUINTBRIDGE × i2.JP -
PREVENT x AZ（Part2）
Prevent CKD progression - use claims data to track behavior change and quantify the effectiveness of the awareness letterPREVENT Inc. -
PREVENT x AZ（Part1）
A data-driven approach to change behavior of those at risk for chronic kidney disease (CKD)PREVENT Inc. -
Life Course Design Consortium x Lanex
Aiming to realize patient-centric healthcare, take data integration and utilization one step furtherLife Course Design Consortium x Lanex -
ExaWizards x AZ
Challenge in developing App that tracks potassium level in a mealExaWizards -
i2.JP Partner Collaboration Cases
Moving forward, online consultation among doctors, utilization of health and medical data, and App development using weather data(Japanese Only)i2.JP -
Celebrating the i2.JP 2nd Anniversary
(Japanese only)i2.JP -
Realizing Patient-Centric Healthcare through DX and Co-Creation
(Japanese only)i2.JP -
Challenge to quantify communication! Konica Minolta -
Challenge to quantify communication! I'mbesideyou -
Co-creation between pharmaceutical company and pharmacy! Sugi Pharmacy -
Deep dive into Public-Private Partnership (PPP)! Osaka Innovation Hub -
-
Why do major pharmas collaborate? Major Pharmas -
“Medication and Self-Management App” for cancer patients
Welby Inc. -
New challenge to deliver awareness for potential asthma patients by “AI-powered questionnaire” Ubie, Inc. -
New medical challenge together with the “telemedicine tech venture” MICIN, Inc.
Challenge Application
READ MORE-
- Unlocking the Potential of Children Who Refuse to Attend School
- Currently, approximately 350,000 elementary and junior high school students refuse to attend school. While negative perceptions of school refusal remain prevalent, a growing perspective views this period as a "preparation phase for designing their future." This approach promotes children's physical and mental well-being, fostering environments where they can live authentically.
Therefore, it is essential that not just families, but society as a whole works to create such environments. As learning environments outside of school expand, we are implementing "school trip" activities that help cultivate the self-efficacy and resilience of children not attending school by harnessing their infinite potential. We welcome inquiries from anyone interested in or wishing to collaborate on our "experiential school trips." These trips connect children with local communities, allowing them to discover the area's appeal while encouraging creative thinking about solutions to local issues.
-
- Improving Blood Pressure Control Rates in Hypertension Treatment
- Currently, more than half of patients taking antihypertensive drugs in Japan have not achieved the blood pressure targets set by guidelines, and challenges remain in blood pressure management. To achieve appropriate blood pressure control, a comprehensive approach is required from both patients and healthcare providers. This approach includes self-care, medication adherence, lifestyle improvements, individualized guidance from healthcare providers, and interdisciplinary collaboration.
In recent years, digital technology and innovation have continued to evolve, generating significant anticipation for new approaches that leverage these advancements. We look forward to receiving diverse proposals aimed at achieving blood pressure targets.
-
- Improving Cancer Screening Rates
- Cancer screenings lead to the early detection and treatment of cancer, which significantly improves treatment outcomes and survival rates. However, cancer screening rates in Japan remain insufficient. In light of this, we are seeking new initiatives and ideas to encourage people who have not previously undergone screening to participate.
-
- Early intervention for COPD
- We are seeking for ideas that may help potential patients recognize that they have COPD and start treatment with a specialist.
-
- Remote home care after treatment
- We are seeking for innovative remote home care monitoring tools or services to evaluate patient conditions after treatment.
Our mission
- Healthcare Open innovation Network
to Realize “Patient Centricity”
i2.JP is an open innovation network to connect healthcare
professionals, local governments, academia and private companies, designed to jointly work out collective and
practical
optimal answers toward the solution of issues
in the healthcare field.
4 missions
i2.JP will tackle
- Realize “patient centricity”
- Deliver added value solution to
healthcare professionals - Discover and develop new technologies
contributing to patients and healthcare professionals - Optimize healthcare systems
Initiatives i2.JP is eager
to promote together with
“partners”
Realize “patient centricity”, deliver added value solution to healthcare professionals, discover and develop new technologies, optimize healthcare systems - all of these are challenges difficult to deliver by a single group or a single individual.
i2.JP will create opportunities of collaboration with start-ups, healthcare professionals, and partners from the private sector, government and academia.
Toward the solution of specific healthcare issues, i2.JP will jointly promote “Think big (comprehension and verbalization of the big picture), start small (understanding and identification of pain points, development of MVP, promotion of PoC), learn and scale fast (learnings from mistakes, market-in and expansion strategy).”
For inquiries
Interested in joining us?
Thank you for your interest. We will get in touch soon.